Global Bovine Mastitis  Market

Bovine Mastitis  Comprehensive Study by Therapy (Lactating Period, Dry Period {Antibiotics, Others}), Mastitis (Clinical mastitis, Sub-Clinical mastitis, Peracute mastitis, Acute mastitis, Subacute mastitis, Chronic mastitis), Route of Administration (Intramammary, Systemic), Mode of transmission (Contagious, Environmental, Opportunist Mastitis), Cause (Streptococcus agalactiae, Staphylococcus aureus, CMycoplasma BovisAgalactiaeoagulase-Negative Staphylococci, Mycoplasma Bovis, Environmental Streptococcus), Animal Type (Cow, Sheep, Goat, Camel, Other), End User (Hospital, Clinics, Veterinary Centers, Others) Players and Region - Global Market Outlook to 2028

Bovine Mastitis  Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 5.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Bovine Mastitis 
Mastitis is the most prevalent production disease in dairy herds worldwide, and it is well documented as a disease with a heavy burden in developed countries, while very minimal information is available for developing countries. Bovine Mastitis is an inflammation of the mammary gland or udder. Mastitis in dairy cows is caused by udder infections, usually resulting from bacteria introduced either during the milking process or from environmental contact. Examples include contamination from milking equipment, milking personnel, manure contamination of dirty stalls. . According to the examination done annual losses per cow from mastitis in the United States of America in 1976 were estimated to be USD 117.35 per cow per year, later these losses had increased to USD 185 to USD 200 per cow per year. The demand for bovine mastitis solutions is booming owing to an increase in the occurrence of mastitis cases on the farm, a consistent decrease in milk yield.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketNorth America
UnitValue (USD Million)
CAGR5.2%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States & Germany Players will contribute the maximum growth to Global Bovine Mastitis  market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Zoetis (United States), Merck and Co., Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco (United States), Ceva (France), West Way Health (Ireland), Virbac (France), Praj Industries Limited (India), Armenta(Israel) and Veyx Pharma GmbH (Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Bovine Mastitis  market by and Region.



On the basis of geography, the market of Bovine Mastitis  has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region held largest market share in the year 2022. If we see Market by Therapy, the sub-segment i.e. Lactating Period will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mastitis , the sub-segment i.e. Clinical mastitis will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Route of Administration, the sub-segment i.e. Intramammary will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Mode of transmission, the sub-segment i.e. Contagious will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cause, the sub-segment i.e. Streptococcus agalactiae will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Animal Type, the sub-segment i.e. Cow will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital will boost the Bovine Mastitis  market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing government body supports

Market Growth Drivers:
The major driving factor of the growth of Bovine Mastitis is a public health risk due to consumption of unsafe milk, and less efficient processing of milk., Growing awareness among dairy farmers regarding treatment is fueling the demand for antibiotics in the treatment of the condition. and The rise in the incidence of the disease among bovine animals

Challenges:
The lack of awareness among farmers of the subclinical form of the diseases and Accounting for the rising competition in the global market

Restraints:
Limited information is available for developing countries

Opportunities:
Mastitis is a global problem as it adversely affects animal health, quality of milk, and the economics of milk production, affecting every country, including developed ones, and causes substantial financial losses is booming the growth opportunities for the Bovine Mastitis  treatment

Market Leaders and their expansionary development strategies
In February 2020 MoooFarm India based building up a stage is Image marking to recognize mastitis in cows, which can help dairy ranchers distinguish mastitis in steers through 'picture naming. The organization has likewise gotten help from US-based programming monster, Microsoft, which has conceded USD USD15,000 to begin chipping away at this stage.
In 2021, Boehringer Ingelheim, a world leader in animal health, today announced the addition of blue Ubroseal nipple inner sealant to its dairy mastitis portfolio to prevent new intra-mammary infections during dry periods.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Bovine Mastitis  Providers, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Therapy
  • Lactating Period
  • Dry Period {Antibiotics, Others}

By Mastitis
  • Clinical mastitis
  • Sub-Clinical mastitis
  • Peracute mastitis
  • Acute mastitis
  • Subacute mastitis
  • Chronic mastitis

By Route of Administration
  • Intramammary
  • Systemic

By Mode of transmission
  • Contagious
  • Environmental
  • Opportunist Mastitis

By Cause
  • Streptococcus agalactiae
  • Staphylococcus aureus
  • CMycoplasma BovisAgalactiaeoagulase-Negative Staphylococci
  • Mycoplasma Bovis
  • Environmental Streptococcus

By Animal Type
  • Cow
  • Sheep
  • Goat
  • Camel
  • Other

By End User
  • Hospital
  • Clinics
  • Veterinary Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The major driving factor of the growth of Bovine Mastitis is a public health risk due to consumption of unsafe milk, and less efficient processing of milk.
      • 3.2.2. Growing awareness among dairy farmers regarding treatment is fueling the demand for antibiotics in the treatment of the condition.
      • 3.2.3. The rise in the incidence of the disease among bovine animals
    • 3.3. Market Challenges
      • 3.3.1. The lack of awareness among farmers of the subclinical form of the diseases
      • 3.3.2. Accounting for the rising competition in the global market
    • 3.4. Market Trends
      • 3.4.1. Increasing government body supports
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bovine Mastitis , by Therapy, Mastitis , Route of Administration, Mode of transmission, Cause, Animal Type, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Bovine Mastitis  (Value)
      • 5.2.1. Global Bovine Mastitis  by: Therapy (Value)
        • 5.2.1.1. Lactating Period
        • 5.2.1.2. Dry Period {Antibiotics, Others}
      • 5.2.2. Global Bovine Mastitis  by: Route of Administration (Value)
        • 5.2.2.1. Intramammary
        • 5.2.2.2. Systemic
      • 5.2.3. Global Bovine Mastitis  by: Mode of transmission (Value)
        • 5.2.3.1. Contagious
        • 5.2.3.2. Environmental
        • 5.2.3.3. Opportunist Mastitis
      • 5.2.4. Global Bovine Mastitis  by: Cause (Value)
        • 5.2.4.1. Streptococcus agalactiae
        • 5.2.4.2. Staphylococcus aureus
        • 5.2.4.3. CMycoplasma BovisAgalactiaeoagulase-Negative Staphylococci
        • 5.2.4.4. Mycoplasma Bovis
        • 5.2.4.5. Environmental Streptococcus
      • 5.2.5. Global Bovine Mastitis  by: Animal Type (Value)
        • 5.2.5.1. Cow
        • 5.2.5.2. Sheep
        • 5.2.5.3. Goat
        • 5.2.5.4. Camel
        • 5.2.5.5. Other
      • 5.2.6. Global Bovine Mastitis  by: End User (Value)
        • 5.2.6.1. Hospital
        • 5.2.6.2. Clinics
        • 5.2.6.3. Veterinary Centers
        • 5.2.6.4. Others
      • 5.2.7. Global Bovine Mastitis  Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Bovine Mastitis : Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck and Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ceva (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. West Way Health (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Virbac (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Praj Industries Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Armenta(Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Veyx Pharma GmbH (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bovine Mastitis  Sale, by Therapy, Mastitis , Route of Administration, Mode of transmission, Cause, Animal Type, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Bovine Mastitis  (Value)
      • 7.2.1. Global Bovine Mastitis  by: Therapy (Value)
        • 7.2.1.1. Lactating Period
        • 7.2.1.2. Dry Period {Antibiotics, Others}
      • 7.2.2. Global Bovine Mastitis  by: Route of Administration (Value)
        • 7.2.2.1. Intramammary
        • 7.2.2.2. Systemic
      • 7.2.3. Global Bovine Mastitis  by: Mode of transmission (Value)
        • 7.2.3.1. Contagious
        • 7.2.3.2. Environmental
        • 7.2.3.3. Opportunist Mastitis
      • 7.2.4. Global Bovine Mastitis  by: Cause (Value)
        • 7.2.4.1. Streptococcus agalactiae
        • 7.2.4.2. Staphylococcus aureus
        • 7.2.4.3. CMycoplasma BovisAgalactiaeoagulase-Negative Staphylococci
        • 7.2.4.4. Mycoplasma Bovis
        • 7.2.4.5. Environmental Streptococcus
      • 7.2.5. Global Bovine Mastitis  by: Animal Type (Value)
        • 7.2.5.1. Cow
        • 7.2.5.2. Sheep
        • 7.2.5.3. Goat
        • 7.2.5.4. Camel
        • 7.2.5.5. Other
      • 7.2.6. Global Bovine Mastitis  by: End User (Value)
        • 7.2.6.1. Hospital
        • 7.2.6.2. Clinics
        • 7.2.6.3. Veterinary Centers
        • 7.2.6.4. Others
      • 7.2.7. Global Bovine Mastitis  Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bovine Mastitis : by Therapy(USD Million)
  • Table 2. Bovine Mastitis  Lactating Period , by Region USD Million (2017-2022)
  • Table 3. Bovine Mastitis  Dry Period {Antibiotics, Others} , by Region USD Million (2017-2022)
  • Table 4. Bovine Mastitis : by Route of Administration(USD Million)
  • Table 5. Bovine Mastitis  Intramammary , by Region USD Million (2017-2022)
  • Table 6. Bovine Mastitis  Systemic , by Region USD Million (2017-2022)
  • Table 7. Bovine Mastitis : by Mode of transmission(USD Million)
  • Table 8. Bovine Mastitis  Contagious , by Region USD Million (2017-2022)
  • Table 9. Bovine Mastitis  Environmental , by Region USD Million (2017-2022)
  • Table 10. Bovine Mastitis  Opportunist Mastitis , by Region USD Million (2017-2022)
  • Table 11. Bovine Mastitis : by Cause(USD Million)
  • Table 12. Bovine Mastitis  Streptococcus agalactiae , by Region USD Million (2017-2022)
  • Table 13. Bovine Mastitis  Staphylococcus aureus , by Region USD Million (2017-2022)
  • Table 14. Bovine Mastitis  CMycoplasma BovisAgalactiaeoagulase-Negative Staphylococci , by Region USD Million (2017-2022)
  • Table 15. Bovine Mastitis  Mycoplasma Bovis , by Region USD Million (2017-2022)
  • Table 16. Bovine Mastitis  Environmental Streptococcus , by Region USD Million (2017-2022)
  • Table 17. Bovine Mastitis : by Animal Type(USD Million)
  • Table 18. Bovine Mastitis  Cow , by Region USD Million (2017-2022)
  • Table 19. Bovine Mastitis  Sheep , by Region USD Million (2017-2022)
  • Table 20. Bovine Mastitis  Goat , by Region USD Million (2017-2022)
  • Table 21. Bovine Mastitis  Camel , by Region USD Million (2017-2022)
  • Table 22. Bovine Mastitis  Other , by Region USD Million (2017-2022)
  • Table 23. Bovine Mastitis : by End User(USD Million)
  • Table 24. Bovine Mastitis  Hospital , by Region USD Million (2017-2022)
  • Table 25. Bovine Mastitis  Clinics , by Region USD Million (2017-2022)
  • Table 26. Bovine Mastitis  Veterinary Centers , by Region USD Million (2017-2022)
  • Table 27. Bovine Mastitis  Others , by Region USD Million (2017-2022)
  • Table 28. South America Bovine Mastitis , by Country USD Million (2017-2022)
  • Table 29. South America Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 30. South America Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 31. South America Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 32. South America Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 33. South America Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 34. South America Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 35. South America Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 36. Brazil Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 37. Brazil Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 38. Brazil Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 39. Brazil Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 40. Brazil Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 41. Brazil Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 42. Brazil Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 43. Argentina Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 44. Argentina Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 45. Argentina Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 46. Argentina Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 47. Argentina Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 48. Argentina Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 49. Argentina Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 50. Rest of South America Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 51. Rest of South America Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 52. Rest of South America Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 53. Rest of South America Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 54. Rest of South America Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 55. Rest of South America Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 56. Rest of South America Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 57. Asia Pacific Bovine Mastitis , by Country USD Million (2017-2022)
  • Table 58. Asia Pacific Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 59. Asia Pacific Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 60. Asia Pacific Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 61. Asia Pacific Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 62. Asia Pacific Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 63. Asia Pacific Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 64. Asia Pacific Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 65. China Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 66. China Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 67. China Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 68. China Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 69. China Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 70. China Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 71. China Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 72. Japan Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 73. Japan Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 74. Japan Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 75. Japan Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 76. Japan Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 77. Japan Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 78. Japan Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 79. India Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 80. India Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 81. India Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 82. India Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 83. India Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 84. India Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 85. India Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 86. South Korea Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 87. South Korea Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 88. South Korea Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 89. South Korea Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 90. South Korea Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 91. South Korea Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 92. South Korea Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 93. Taiwan Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 94. Taiwan Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 95. Taiwan Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 96. Taiwan Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 97. Taiwan Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 98. Taiwan Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 99. Taiwan Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 100. Australia Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 101. Australia Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 102. Australia Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 103. Australia Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 104. Australia Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 105. Australia Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 106. Australia Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 107. Rest of Asia-Pacific Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 108. Rest of Asia-Pacific Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 109. Rest of Asia-Pacific Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 110. Rest of Asia-Pacific Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 111. Rest of Asia-Pacific Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 112. Rest of Asia-Pacific Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 113. Rest of Asia-Pacific Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 114. Europe Bovine Mastitis , by Country USD Million (2017-2022)
  • Table 115. Europe Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 116. Europe Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 117. Europe Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 118. Europe Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 119. Europe Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 120. Europe Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 121. Europe Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 122. Germany Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 123. Germany Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 124. Germany Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 125. Germany Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 126. Germany Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 127. Germany Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 128. Germany Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 129. France Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 130. France Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 131. France Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 132. France Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 133. France Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 134. France Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 135. France Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 136. Italy Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 137. Italy Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 138. Italy Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 139. Italy Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 140. Italy Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 141. Italy Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 142. Italy Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 143. United Kingdom Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 144. United Kingdom Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 145. United Kingdom Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 146. United Kingdom Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 147. United Kingdom Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 148. United Kingdom Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 149. United Kingdom Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 150. Netherlands Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 151. Netherlands Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 152. Netherlands Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 153. Netherlands Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 154. Netherlands Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 155. Netherlands Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 156. Netherlands Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 157. Rest of Europe Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 158. Rest of Europe Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 159. Rest of Europe Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 160. Rest of Europe Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 161. Rest of Europe Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 162. Rest of Europe Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 163. Rest of Europe Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 164. MEA Bovine Mastitis , by Country USD Million (2017-2022)
  • Table 165. MEA Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 166. MEA Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 167. MEA Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 168. MEA Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 169. MEA Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 170. MEA Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 171. MEA Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 172. Middle East Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 173. Middle East Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 174. Middle East Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 175. Middle East Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 176. Middle East Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 177. Middle East Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 178. Middle East Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 179. Africa Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 180. Africa Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 181. Africa Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 182. Africa Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 183. Africa Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 184. Africa Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 185. Africa Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 186. North America Bovine Mastitis , by Country USD Million (2017-2022)
  • Table 187. North America Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 188. North America Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 189. North America Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 190. North America Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 191. North America Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 192. North America Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 193. North America Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 194. United States Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 195. United States Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 196. United States Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 197. United States Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 198. United States Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 199. United States Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 200. United States Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 201. Canada Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 202. Canada Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 203. Canada Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 204. Canada Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 205. Canada Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 206. Canada Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 207. Canada Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 208. Mexico Bovine Mastitis , by Therapy USD Million (2017-2022)
  • Table 209. Mexico Bovine Mastitis , by Mastitis USD Million (2017-2022)
  • Table 210. Mexico Bovine Mastitis , by Route of Administration USD Million (2017-2022)
  • Table 211. Mexico Bovine Mastitis , by Mode of transmission USD Million (2017-2022)
  • Table 212. Mexico Bovine Mastitis , by Cause USD Million (2017-2022)
  • Table 213. Mexico Bovine Mastitis , by Animal Type USD Million (2017-2022)
  • Table 214. Mexico Bovine Mastitis , by End User USD Million (2017-2022)
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Company Basic Information, Sales Area and Its Competitors
  • Table 219. Company Basic Information, Sales Area and Its Competitors
  • Table 220. Company Basic Information, Sales Area and Its Competitors
  • Table 221. Company Basic Information, Sales Area and Its Competitors
  • Table 222. Company Basic Information, Sales Area and Its Competitors
  • Table 223. Company Basic Information, Sales Area and Its Competitors
  • Table 224. Company Basic Information, Sales Area and Its Competitors
  • Table 225. Bovine Mastitis : by Therapy(USD Million)
  • Table 226. Bovine Mastitis  Lactating Period , by Region USD Million (2023-2028)
  • Table 227. Bovine Mastitis  Dry Period {Antibiotics, Others} , by Region USD Million (2023-2028)
  • Table 228. Bovine Mastitis : by Route of Administration(USD Million)
  • Table 229. Bovine Mastitis  Intramammary , by Region USD Million (2023-2028)
  • Table 230. Bovine Mastitis  Systemic , by Region USD Million (2023-2028)
  • Table 231. Bovine Mastitis : by Mode of transmission(USD Million)
  • Table 232. Bovine Mastitis  Contagious , by Region USD Million (2023-2028)
  • Table 233. Bovine Mastitis  Environmental , by Region USD Million (2023-2028)
  • Table 234. Bovine Mastitis  Opportunist Mastitis , by Region USD Million (2023-2028)
  • Table 235. Bovine Mastitis : by Cause(USD Million)
  • Table 236. Bovine Mastitis  Streptococcus agalactiae , by Region USD Million (2023-2028)
  • Table 237. Bovine Mastitis  Staphylococcus aureus , by Region USD Million (2023-2028)
  • Table 238. Bovine Mastitis  CMycoplasma BovisAgalactiaeoagulase-Negative Staphylococci , by Region USD Million (2023-2028)
  • Table 239. Bovine Mastitis  Mycoplasma Bovis , by Region USD Million (2023-2028)
  • Table 240. Bovine Mastitis  Environmental Streptococcus , by Region USD Million (2023-2028)
  • Table 241. Bovine Mastitis : by Animal Type(USD Million)
  • Table 242. Bovine Mastitis  Cow , by Region USD Million (2023-2028)
  • Table 243. Bovine Mastitis  Sheep , by Region USD Million (2023-2028)
  • Table 244. Bovine Mastitis  Goat , by Region USD Million (2023-2028)
  • Table 245. Bovine Mastitis  Camel , by Region USD Million (2023-2028)
  • Table 246. Bovine Mastitis  Other , by Region USD Million (2023-2028)
  • Table 247. Bovine Mastitis : by End User(USD Million)
  • Table 248. Bovine Mastitis  Hospital , by Region USD Million (2023-2028)
  • Table 249. Bovine Mastitis  Clinics , by Region USD Million (2023-2028)
  • Table 250. Bovine Mastitis  Veterinary Centers , by Region USD Million (2023-2028)
  • Table 251. Bovine Mastitis  Others , by Region USD Million (2023-2028)
  • Table 252. South America Bovine Mastitis , by Country USD Million (2023-2028)
  • Table 253. South America Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 254. South America Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 255. South America Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 256. South America Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 257. South America Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 258. South America Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 259. South America Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 260. Brazil Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 261. Brazil Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 262. Brazil Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 263. Brazil Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 264. Brazil Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 265. Brazil Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 266. Brazil Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 267. Argentina Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 268. Argentina Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 269. Argentina Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 270. Argentina Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 271. Argentina Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 272. Argentina Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 273. Argentina Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 274. Rest of South America Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 275. Rest of South America Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 276. Rest of South America Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 277. Rest of South America Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 278. Rest of South America Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 279. Rest of South America Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 280. Rest of South America Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 281. Asia Pacific Bovine Mastitis , by Country USD Million (2023-2028)
  • Table 282. Asia Pacific Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 283. Asia Pacific Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 284. Asia Pacific Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 285. Asia Pacific Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 286. Asia Pacific Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 287. Asia Pacific Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 288. Asia Pacific Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 289. China Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 290. China Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 291. China Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 292. China Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 293. China Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 294. China Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 295. China Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 296. Japan Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 297. Japan Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 298. Japan Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 299. Japan Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 300. Japan Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 301. Japan Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 302. Japan Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 303. India Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 304. India Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 305. India Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 306. India Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 307. India Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 308. India Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 309. India Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 310. South Korea Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 311. South Korea Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 312. South Korea Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 313. South Korea Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 314. South Korea Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 315. South Korea Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 316. South Korea Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 317. Taiwan Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 318. Taiwan Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 319. Taiwan Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 320. Taiwan Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 321. Taiwan Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 322. Taiwan Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 323. Taiwan Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 324. Australia Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 325. Australia Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 326. Australia Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 327. Australia Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 328. Australia Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 329. Australia Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 330. Australia Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 331. Rest of Asia-Pacific Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 332. Rest of Asia-Pacific Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 333. Rest of Asia-Pacific Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 334. Rest of Asia-Pacific Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 335. Rest of Asia-Pacific Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 336. Rest of Asia-Pacific Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 337. Rest of Asia-Pacific Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 338. Europe Bovine Mastitis , by Country USD Million (2023-2028)
  • Table 339. Europe Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 340. Europe Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 341. Europe Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 342. Europe Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 343. Europe Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 344. Europe Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 345. Europe Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 346. Germany Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 347. Germany Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 348. Germany Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 349. Germany Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 350. Germany Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 351. Germany Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 352. Germany Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 353. France Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 354. France Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 355. France Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 356. France Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 357. France Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 358. France Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 359. France Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 360. Italy Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 361. Italy Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 362. Italy Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 363. Italy Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 364. Italy Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 365. Italy Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 366. Italy Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 367. United Kingdom Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 368. United Kingdom Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 369. United Kingdom Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 370. United Kingdom Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 371. United Kingdom Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 372. United Kingdom Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 373. United Kingdom Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 374. Netherlands Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 375. Netherlands Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 376. Netherlands Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 377. Netherlands Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 378. Netherlands Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 379. Netherlands Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 380. Netherlands Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 381. Rest of Europe Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 382. Rest of Europe Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 383. Rest of Europe Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 384. Rest of Europe Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 385. Rest of Europe Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 386. Rest of Europe Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 387. Rest of Europe Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 388. MEA Bovine Mastitis , by Country USD Million (2023-2028)
  • Table 389. MEA Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 390. MEA Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 391. MEA Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 392. MEA Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 393. MEA Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 394. MEA Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 395. MEA Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 396. Middle East Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 397. Middle East Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 398. Middle East Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 399. Middle East Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 400. Middle East Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 401. Middle East Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 402. Middle East Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 403. Africa Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 404. Africa Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 405. Africa Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 406. Africa Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 407. Africa Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 408. Africa Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 409. Africa Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 410. North America Bovine Mastitis , by Country USD Million (2023-2028)
  • Table 411. North America Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 412. North America Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 413. North America Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 414. North America Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 415. North America Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 416. North America Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 417. North America Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 418. United States Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 419. United States Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 420. United States Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 421. United States Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 422. United States Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 423. United States Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 424. United States Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 425. Canada Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 426. Canada Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 427. Canada Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 428. Canada Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 429. Canada Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 430. Canada Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 431. Canada Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 432. Mexico Bovine Mastitis , by Therapy USD Million (2023-2028)
  • Table 433. Mexico Bovine Mastitis , by Mastitis USD Million (2023-2028)
  • Table 434. Mexico Bovine Mastitis , by Route of Administration USD Million (2023-2028)
  • Table 435. Mexico Bovine Mastitis , by Mode of transmission USD Million (2023-2028)
  • Table 436. Mexico Bovine Mastitis , by Cause USD Million (2023-2028)
  • Table 437. Mexico Bovine Mastitis , by Animal Type USD Million (2023-2028)
  • Table 438. Mexico Bovine Mastitis , by End User USD Million (2023-2028)
  • Table 439. Research Programs/Design for This Report
  • Table 440. Key Data Information from Secondary Sources
  • Table 441. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bovine Mastitis : by Therapy USD Million (2017-2022)
  • Figure 5. Global Bovine Mastitis : by Route of Administration USD Million (2017-2022)
  • Figure 6. Global Bovine Mastitis : by Mode of transmission USD Million (2017-2022)
  • Figure 7. Global Bovine Mastitis : by Cause USD Million (2017-2022)
  • Figure 8. Global Bovine Mastitis : by Animal Type USD Million (2017-2022)
  • Figure 9. Global Bovine Mastitis : by End User USD Million (2017-2022)
  • Figure 10. South America Bovine Mastitis  Share (%), by Country
  • Figure 11. Asia Pacific Bovine Mastitis  Share (%), by Country
  • Figure 12. Europe Bovine Mastitis  Share (%), by Country
  • Figure 13. MEA Bovine Mastitis  Share (%), by Country
  • Figure 14. North America Bovine Mastitis  Share (%), by Country
  • Figure 15. Global Bovine Mastitis  share by Players 2022 (%)
  • Figure 16. Global Bovine Mastitis  share by Players (Top 3) 2022(%)
  • Figure 17. Global Bovine Mastitis  share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 20. Zoetis (United States) Revenue: by Geography 2022
  • Figure 21. Merck and Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Merck and Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2022
  • Figure 25. Elanco (United States) Revenue, Net Income and Gross profit
  • Figure 26. Elanco (United States) Revenue: by Geography 2022
  • Figure 27. Ceva (France) Revenue, Net Income and Gross profit
  • Figure 28. Ceva (France) Revenue: by Geography 2022
  • Figure 29. West Way Health (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. West Way Health (Ireland) Revenue: by Geography 2022
  • Figure 31. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 32. Virbac (France) Revenue: by Geography 2022
  • Figure 33. Praj Industries Limited (India) Revenue, Net Income and Gross profit
  • Figure 34. Praj Industries Limited (India) Revenue: by Geography 2022
  • Figure 35. Armenta(Israel) Revenue, Net Income and Gross profit
  • Figure 36. Armenta(Israel) Revenue: by Geography 2022
  • Figure 37. Veyx Pharma GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Veyx Pharma GmbH (Germany) Revenue: by Geography 2022
  • Figure 39. Global Bovine Mastitis : by Therapy USD Million (2023-2028)
  • Figure 40. Global Bovine Mastitis : by Route of Administration USD Million (2023-2028)
  • Figure 41. Global Bovine Mastitis : by Mode of transmission USD Million (2023-2028)
  • Figure 42. Global Bovine Mastitis : by Cause USD Million (2023-2028)
  • Figure 43. Global Bovine Mastitis : by Animal Type USD Million (2023-2028)
  • Figure 44. Global Bovine Mastitis : by End User USD Million (2023-2028)
  • Figure 45. South America Bovine Mastitis  Share (%), by Country
  • Figure 46. Asia Pacific Bovine Mastitis  Share (%), by Country
  • Figure 47. Europe Bovine Mastitis  Share (%), by Country
  • Figure 48. MEA Bovine Mastitis  Share (%), by Country
  • Figure 49. North America Bovine Mastitis  Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Zoetis (United States)
  • Merck and Co., Inc. (United States)
  • Boehringer Ingelheim International GmbH (Germany)
  • Elanco (United States)
  • Ceva (France)
  • West Way Health (Ireland)
  • Virbac (France)
  • Praj Industries Limited (India)
  • Armenta(Israel)
  • Veyx Pharma GmbH (Germany)
Select User Access Type

Key Highlights of Report


Apr 2024 154 Pages 94 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bovine Mastitis  Market Quantitative research analysis
Global Bovine Mastitis  Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Zoetis (United States), Merck and Co., Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco (United States), Ceva (France), West Way Health (Ireland), Virbac (France), Praj Industries Limited (India), Armenta(Israel) and Veyx Pharma GmbH (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing government body supports" is seen as one of major influencing trends for Bovine Mastitis  Market during projected period 2022-2028.
The Bovine Mastitis  market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Bovine Mastitis  Market Report?

Have a Query? Click Here

Other Related Reports

Histopathology Services Comprehensive Study by Examination (Surgical Specimen, Breast Biopsy, Gastrointestinal Biopsy, Testicular Biopsy, Lung Biopsy, Renal Biopsy, Biopsy of Gynecological Cancers, L...
$ 3750
Vaccine Storage & Packaging Comprehensive Study by Type (Vaccine Storage, Vaccine Packaging), Vaccine Packaging (Packaging (Vaccine Cool Bags, Vials, and Ampoules, Corrugated Boxes, Others), Packagin...
$ 3750
Animal Treatment Comprehensive Study by Type (Pharmaceuticals, Feed Additives), Application (Laboratory Services, Animal Emergency Care, Pain Management, Animal Specialty Services, Vitamins and Suppl...
$ 3650
Lymphedema Diagnostics Comprehensive Study by Application (Lymphedema Surgery Center, Hospitals, Clinics), Diagnostic Tests (MRI Scan, CT Scan, Doppler Ultrasound, Lymphoscintigraphy), Disease Type (...
$ 3750
Veterinary Care Comprehensive Study by Type (Therapeutics (Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives, Others), Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagn...
$ 3750
Elastography Imaging Comprehensive Study by Application (Cardiology, OB/GYN, Urology, Vascular, Radiology/General Imaging, Orthopedic and Musculoskeletal Applications, Others), Modality (Ultrasound E...
$ 3650